Biomarker Clinical Trials in Guangzhou, Guangdong
3 recruitingGuangzhou, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma
Hepatocellular CarcinomaRadiotherapyTreatment Outcome+2 more
Nanfang Hospital, Southern Medical University260 enrolled1 locationNCT06864221
Recruiting
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
ImmunotherapyBiomarkerHyperprogression
Nanfang Hospital, Southern Medical University374 enrolled5 locationsNCT06276088
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Head and Neck CancerNasopharyngeal CarcinomaBiomarker+1 more
Nanfang Hospital, Southern Medical University300 enrolled5 locationsNCT06307314